PGHLBSEProcter & Gamble Health LtdMediumNeutral
Announced Tue, 26 May · 17:27 IST

Dear Sir, Please find attached intimation for re appointment of Independent Director.

Management Changes View source PDF

PGHL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+6.1%1-day move
₹5662.00
prior close
₹5949.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+3.8+5.5+10.0+6.5+6.1+6.7+6.2+7.7+9.2+9.1+11.5+10.5+19.9
Up moveDown movePending
AI summary

Procter & Gamble Health Ltd has announced the re-appointment of Mr. S. Madhavan as Independent Director for a second term of five years, from November 15, 2026 to November 14, 2031. The Board of Directors approved this re-appointment based on the recommendation of the Nomination & Remuneration Committee. The appointment is subject to shareholder approval at the upcoming general meeting. The company has confirmed that Mr. Madhavan meets the independence criteria under Section 149 of the Companies Act, 2013 and the SEBI Listing Regulations. He does not hold any shares in the company and is not related to any other directors.

Likely market impact

This is a routine corporate governance action indicating continuity in board independence. The re-appointment maintains board stability and expertise without any material impact on shareholders. The stock is unlikely to see any significant reaction to this announcement.